Here, we are going to share Laurus Labs Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.
Laurus Labs Ltd is a strong player in the pharmaceutical and biotechnology sectors in India. Founded in 2005, the company focuses on developing and manufacturing generic APIs, formulations, and contract research services.
With a commitment to innovation and quality, Laurus Labs has established itself as a leader in the production of complex generics, especially in the areas of anti-retroviral drugs.
Laurus Labs Company Overview
- Founded: 2005
- Headquarters: Hyderabad, India
- Industry: Pharmaceuticals and Biotechnology
- Market Capitalization: Approximately ₹25,518.41 Crores (as of September 2024)
- Current Share Price: ₹473.30 (as of September 23, 2024)
- Stock Performance: Shares are near 52-week high levels, indicating strong market confidence.
Laurus Labs Share Key Information
| Company Name | Laurus Labs Ltd |
| Headquarters | Hyderabad |
| Sectors | Pharmaceuticals and Biotechnology |
| Market Cap | ₹ 25,518.41 Cr. |
| No. of Shares | 53.92Cr. |
| Book Value | ₹78.17 |
| Dividend Yield | 0.17% |
| ROCE | 7.54% |
| ROE | 5.44% |
| Face Value | ₹2 |
| Sales Growth | -16.65% |
| Profit Growth | -70.58% |
Laurus Labs Business Sector
Laurus Labs operates primarily in the pharmaceutical and biotechnology sector, focusing on the following areas:
- Active Pharmaceutical Ingredients (APIs): Manufacturing complex APIs for various therapeutic areas.
- Formulations: Developing and producing finished dosage forms, particularly for ARVs and oncology.
- Contract Research and Manufacturing Services (CRAMS): Offering research and manufacturing services to global pharmaceutical companies.
Board Members
- Dr. Satyanarayana Chava: Founder and CEO
- Mr. R. S. Raghavan: Chief Financial Officer
- Dr. R. S. Raghavan: Non-Executive Director
Laurus Labs Share Quarterly Results
| PARTICULARS | Mar 2024 | Jun 2024 |
|---|---|---|
| Net Sales | 1,414.52 | 1,116.93 |
| Total Expenditure | 1,143.41 | 955.54 |
| Operating Profit | 271.11 | 161.39 |
| Other Income | 24.09 | 9.30 |
| Interest | 41.99 | 40.89 |
| Depreciation | 88.90 | 91 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 164.31 | 38.80 |
| Tax | 42.99 | 10.02 |
| Profit After Tax | 121.32 | 28.78 |
| Adjusted EPS (Rs) | 2.25 | 0.53 |
Laurus Labs Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 5,773.45 | 4,812.39 |
| Total Expenditure | 4,291.69 | 4,062.51 |
| Operating Profit | 1,481.76 | 749.88 |
| Other Income | 15.95 | 47.42 |
| Interest | 145.70 | 150.82 |
| Depreciation | 300.58 | 345.01 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 1,051.43 | 301.47 |
| Tax | 291.05 | 77.77 |
| Net Profit | 760.38 | 223.70 |
| Adjusted EPS (Rs.) | 14.12 | 4.15 |
Laurus Labs Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹493 | ₹520 |
| 2026 | ₹527 | ₹582 |
| 2027 | ₹584 | ₹639 |
| 2028 | ₹649 | ₹711 |
| 2029 | ₹715 | ₹771 |
| 2030 | ₹782 | ₹858 |
| 2035 | ₹1085 | ₹1195 |
| 2040 | ₹1365 | ₹1550 |
Laurus Labs Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹493 |
| February 2025 | ₹495 |
| March 2025 | ₹499 |
| April 2025 | ₹497 |
| May 2025 | ₹501 |
| June 2025 | ₹507 |
| July 2025 | ₹513 |
| August 2025 | ₹510 |
| September 2025 | ₹516 |
| October 2025 | ₹521 |
| November 2025 | ₹518 |
| December 2025 | ₹520 |
Laurus Labs Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹527 |
| February 2026 | ₹533 |
| March 2026 | ₹539 |
| April 2026 | ₹543 |
| May 2026 | ₹549 |
| June 2026 | ₹555 |
| July 2026 | ₹559 |
| August 2026 | ₹556 |
| September 2026 | ₹562 |
| October 2026 | ₹571 |
| November 2026 | ₹577 |
| December 2026 | ₹582 |
Laurus Labs Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹584 |
| February 2027 | ₹589 |
| March 2027 | ₹595 |
| April 2027 | ₹602 |
| May 2027 | ₹599 |
| June 2027 | ₹607 |
| July 2027 | ₹621 |
| August 2027 | ₹633 |
| September 2027 | ₹618 |
| October 2027 | ₹611 |
| November 2027 | ₹625 |
| December 2027 | ₹639 |
Laurus Labs Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹649 |
| February 2028 | ₹656 |
| March 2028 | ₹671 |
| April 2028 | ₹665 |
| May 2028 | ₹677 |
| June 2028 | ₹685 |
| July 2028 | ₹691 |
| August 2028 | ₹688 |
| September 2028 | ₹695 |
| October 2028 | ₹699 |
| November 2028 | ₹702 |
| December 2028 | ₹711 |
Laurus Labs Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹715 |
| February 2029 | ₹719 |
| March 2029 | ₹724 |
| April 2029 | ₹733 |
| May 2029 | ₹728 |
| June 2029 | ₹735 |
| July 2029 | ₹744 |
| August 2029 | ₹759 |
| September 2029 | ₹765 |
| October 2029 | ₹758 |
| November 2029 | ₹766 |
| December 2029 | ₹771 |
Laurus Labs Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹782 |
| February 2030 | ₹789 |
| March 2030 | ₹799 |
| April 2030 | ₹795 |
| May 2030 | ₹805 |
| June 2030 | ₹811 |
| July 2030 | ₹821 |
| August 2030 | ₹835 |
| September 2030 | ₹828 |
| October 2030 | ₹841 |
| November 2030 | ₹845 |
| December 2030 | ₹858 |
Laurus Labs Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹1085 |
| April 2035 | ₹1105 |
| July 2035 | ₹1156 |
| October 2035 | ₹1165 |
| December 2035 | ₹1195 |
Laurus Labs Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹1365 |
| April 2040 | ₹1395 |
| July 2040 | ₹1425 |
| October 2040 | ₹1485 |
| December 2040 | ₹1550 |
Laurus Labs Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 27.18% |
| FIIs | 25.67% |
| DIIs | 13.56% |
| Others | 0% |
| Public | 33.59% |
Laurus Labs Company Competitors
- Natco Pharma Ltd
- Emcure Pharma
- Piramal Pharma
- Suven Pharma
- Granules India
Bull Case of Laurus Labs (Reasons to Invest)
- Strong Market Position: Laurus Labs holds a significant market share in the ARV segment, which is expected to grow due to increasing global demand for these medications.
- Strong R&D Pipeline: The company has a diverse pipeline of products under development, which could drive future revenue growth.
- Expansion Initiatives: Recent investments in R&D facilities and manufacturing capabilities position Laurus Labs for future success.
- Global Partnerships: Collaborations with international pharmaceutical companies enhance its market presence and credibility.
Bear Case of Laurus Labs (Risks Involved)
- Regulatory Risks: As a pharmaceutical company, Laurus Labs faces risks related to regulatory compliance and potential delays in approvals.
- Market Competition: Intense competition in the pharmaceutical sector could impact pricing and margins.
- Economic Factors: Global economic downturns or changes in healthcare policies may affect sales and profitability.
- Dependence on ARVs: A significant portion of revenue comes from ARVs, making the company vulnerable to changes in demand in this specific segment.
Laurus Labs Share Price Target: FAQ
What will be the target of Laurus Labs Share for the year 2025?
By the end of the year 2025, its share price can reach ₹520.
What will be the target of Laurus Labs Share for the year 2026?
By the end of the year 2026, its share price can reach ₹582.
What will be the target of Laurus Labs Share for the year 2027?
By the end of the year 2027, its share price can reach ₹639.
What will be the target of Laurus Labs Share for the year 2028?
By the end of the year 2028, its share price can reach ₹711.
What will be the target of Laurus Labs Share for the year 2029?
By the end of the year 2029, its share price can reach ₹771.
What will be the target of Laurus Labs Share for the year 2030?
By the end of the year 2030 its share price can reach ₹858.
What is the Current market cap of Laurus Labs company?
At present the market cap of this company is ₹ 25,518.41 Cr.
What is the NSE symbol of Laurus Labs company?
The symbol of this company in NSE exchange is LAURUSLABS.
What is the BSE symbol of Laurus Labs company?
The symbol of this company in BSE exchange is 540222.
Read Also:
Natco Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals
Suven Pharma Share Price Target 2025 to 2040 Forecast & Fundamentals
Reliance Power Share Price Target 2025 to 2040 Forecast & Fundamentals
